Picture: 123RF/KENG PO LEUNG
Loading ...

Steven Schultz from Momentum chose Adcock Ingram as his stock pick of the day.

“My stock is Adcock Ingram, well known for Panado, it currently has about 65% of its revenue from prescriptions and over-the-counter meds and around 25% from hospital drug usage. It’s significantly derated this year and went down around 29% over the past 12 months.”

Loading ...
Loading ...
Loading ...
View Comments